• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 ALIGN® S URETHRAL SUPPORT SYSTEM SUPRAPUBIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 ALIGN® S URETHRAL SUPPORT SYSTEM SUPRAPUBIC Back to Search Results
Model Number BRD200S
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Injury (2348); Prolapse (2475); Blood Loss (2597)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The sample was not returned.The finished product met all specifications prior to being released for general distribution.The instructions for use which accompanies all devices currently addresses potential risks associated with surgically implanted materials.The instructions for use states in the adverse events: ¿complications associated with the proper implantation of the align® urethral support system may include, but are not limited to: postoperative hematoma, which may occur following the implant procedure.Temporary urinary retention, bladder outlet obstruction, and voiding difficulties associated with over-correction/too much tension placed on the mesh sling implant.Perforations or lacerations of vessels, nerves, bladder or any viscera, which may occur during introducer needle passage.Transitory irritation at the operative wound site, which may elicit a foreign body response that leads to inflammation, infection, or erosion of the implant." (b)(4).
 
Event or Problem Description
The patient's attorney alleged a deficiency against the device.Per additional information received, the patient has experience more than average bleeding, right side of the periurethral space a significant bleeder, blood loss, vaginal vault prolapse, cystocele, rectocele, apical vault prolapse, enterocele (prolapse), extensive adhesions of small intestine to anterior abdominal wall and right adnexal adhesions to apex of vagina, loops of adherent bowel with double-strand of permanent prolene suture, captured a portion of bowel, suture material in fibrous tissue, stalk (foreign body in patient), adherence of right tube, right ovary to the anterior vaginal wall, and required nonsurgical and additional surgical interventions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALIGN® S URETHRAL SUPPORT SYSTEM SUPRAPUBIC
Common Device Name
ALIGN® S URETHRAL SUPPORT SYSTEM SUPRAPUBIC
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
MDR Report Key9622090
Report Number1018233-2020-00494
Device Sequence Number16874458
Product Code OTN
UDI-Device Identifier00801741016189
UDI-Public(01)00801741016189
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K093747
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2010
Reporter Type Manufacturer
Report Source other
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 01/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/30/2011
Device Model NumberBRD200S
Device Catalogue NumberBRD200S
Device Lot NumberHUTH1994
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Device Age5 MO
Event Location Hospital
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/09/2020
Initial Report FDA Received Date01/23/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age42 YR
-
-